Searched for
AHMEDABAD INJECTABLE PLANT
Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...- Zydus Biologics’ Ahmedabad injectable facility gets 7 observations in USFDA inspectionZydus Lifesciences has made headlines as its Zydus Biologics injectable plant in Ahmedabad underwent a USFDA inspection between April 27 an...
- Zydus Lifesciences shares in focus after Ahmedabad oncology injectable plant gets two FDA observationsZydus Lifesciences shares: The follow-up audit, conducted under Good Manufacturing Practices (GMP), took place from June 9 to June 18, 2025...
- Aurobindo Pharma taps PEs for stake sale in injectable businessAs part of expanding the injectable business, Aurobindo is setting up a dedicated injectable facility in Vizag for the EU and other global ...
- Amneal Pharma to set up plant in GujaratThe NYSE-listed, $2-billion drug maker by sales (2020), which is foraying into India's domestic formulations segment with focus on biologic...
- Cadila Healthcare surges 7% on receiving USFDA approval for levofloxacin injectionThe stock climbed 7.18 per cent to hit a high of Rs 504.8 on BSE.
- Claris Lifesciences shares up 3.5 per cent on BSEStock of Claris Life ended the day 3.56 per cent higher at Rs 181.60 on the BSE. In intra-day, it gained 6.33 per cent to Rs 186.45.
- Claris Lifesciences gets Medicines and Healthcare products Regulatory Agency's nod for new plant"This is the first regulatory inspection and compliance approval conducted by MHRA-UK in line with the EU GMP regulations for plant 2."
- Zydus to invest Rs 100 crore in Vadodara unit, expand hospital businessZydus Hospitals & Healthcare Research recently started its first hospital operations at Anand, better known as Amul's hometown.
- Lincoln Pharma net profit up by 88.76%, plans USFDA plantAhmedabad based drug maker, Lincoln Pharmaceuticals Ltd’s net profit surged by 88.76% for the year ended on March 2013.
- Lincoln Pharma net profit up by 88.76 %, plans USFDA plantLincoln Pharma net profit up by 88.76%. Plans to set up USFDA approved plant to cater domestic and regulatory markets.
- Claris Lifesciences inks JV with Japanese drug maker Otsuka Pharma & Mitsui for Indian marketAhmedabad-based Claris Lifesciences Limited, India executed agreements for a Joint Venture with two Japan-based drug makers Otsuka Pharmace...
- Mitsui in talks to invest Rs 250 crore in ClarisSources said the Japanese group's healthcare company might pick up stake from private equity players invested in Claris or invest in a join...
- Morgan Stanley, Barclays buy Claris bulk shares in open market on USFDA clearanceClaris said it has formally received the letter from USFDA stating that it has completed its evaluation of the firm's corrective actions.
- Claris Lifesciences to resume export to US post USFDA nodThe approval will allow Claris to manufacture and sell its products in te US and also receive abbreviated new drug application approvals, t...
- USFDA to inspect facilities of Zydus, Claris Lifesciences for violating American drug manufacturing normsFDA had issued warning letter for Cadila's injectable unit at its plant in July for not meeting US drug manufacturing norms .
- Claris receives MHRA approval for Ahmedabad unitClaris Lifesciences Limited today announced that it has received approval for its plant at Ahmedabad from the MHRA of the United Kingdom.
- Claris gets nod for Rs 300-crore IPOClaris Lifesciences Ltd, has finally received approval from SEBI for its maiden public issue to raise Rs 300 crore.
- The pain killerFor Ketan Patel, 52, CMD of Troikaa Pharmaceuticals, his business is all about pain and Patel is always on the fast-track to formulate pain...
- The needle of life for Claris LifesciencesClaris Lifesciences’ niche lies in developing cheap injectibles.
Load More
